John P. Schmid - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp (HLXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp (HLXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Helix Acquisition Corp (HLXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net sale of 223,334 shares made by Beth Hecht , a net sale of 110,000 shares made by Kevin Mcculloch , and a net sale of 257,900 shares made by John Johnson .

In summary, during the past 3 months, insiders sold 224,998 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 224,998 shares. During the past 18 months, 896,949 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 871,949 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 1 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 20,645. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 65,713 shares made by Eric J Loumeau , a net sale of 33,511 shares made by Dennis Mulroy , and a net sale of 56,471 shares made by Daniel Faga .

In summary, during the past 3 months, insiders sold 0 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 240,030 shares of AnaptysBio Inc (ANAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 240,030 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net sale of 562,627 shares made by Arsani William ,

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 562,627 shares of Design Therapeutics Inc (DSGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 562,627 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 466,261 shares made by Kristian Reich , a net sale of 150,000 shares made by Matthias Bodenstedt , and a net sale of 500,000 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 470,349 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 470,349 shares. During the past 18 months, 11,400,609 shares of MoonLake Immunotherapeutics (MLTX) were sold and 10,870 shares were bought by its insiders, resulting in a net sale of 11,389,739 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of BridgeBio Oncology Therapeutics Inc (BBOT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BridgeBio Oncology Therapeutics Inc (BBOT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BridgeBio Oncology Therapeutics Inc (BBOT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in Helix Acquisition Corp III (HLXC). Other recent insider transactions involving Helix Acquisition Corp III (HLXC) include a net purchase of 800,000 shares made by Bihua Chen ,

In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp III (HLXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp III (HLXC) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Helix Acquisition Corp III (HLXC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in First Tracks Biotherapeutics Inc (TRAX). Other recent insider transactions involving First Tracks Biotherapeutics Inc (TRAX) include a net sale of 4,705,575 shares made by Ecor1 Capital, Llc , and a net sale of 39,265 shares made by J. Anthony Ware .

In summary, during the past 3 months, insiders sold 39,265 shares of First Tracks Biotherapeutics Inc (TRAX) in total and bought 0 shares, with a net sale of 39,265 shares. During the past 18 months, 4,744,840 shares of First Tracks Biotherapeutics Inc (TRAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,744,840 shares.

First Tracks Biotherapeutics Inc (TRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 1 insider transaction in BlossomHill Therapeutics Inc (BLSM) with a net purchase of 6,000. Other recent insider transactions involving BlossomHill Therapeutics Inc (BLSM) include a net purchase of 625,000 shares made by Carl L Gordon , a net purchase of 625,000 shares made by Orbimed Advisors Llc , and a net purchase of 312,500 shares made by Bihua Chen .

In summary, during the past 3 months, insiders sold 0 shares of BlossomHill Therapeutics Inc (BLSM) in total and bought 1,573,900 shares, with a net purchase of 1,573,900 shares. During the past 18 months, 0 shares of BlossomHill Therapeutics Inc (BLSM) were sold and 1,573,900 shares were bought by its insiders, resulting in a net purchase of 1,573,900 shares.

BlossomHill Therapeutics Inc (BLSM)'s detailed insider trading history can be found in Insider Trading Tracker table.